[ News ]
Welcome to XVir® Therapeutics - The YB-1 Company®
XVir® Therapeutics GmbH is a biopharmaceutical company, which provides YB-1 dependent oncolytic adenoviruses for the treatment of cancer and in particular multidrug-resistant cancer.
Detailed information about the company will be up shortly right here with the XVir®-website! Sign up here if you wish to be informed when the site is launched:
your first name:
your last name:
XVir® and The YB-1 Company® are registered Trademarks of XVir® Therapeutics GmbH
XVir® Therapeutics GmbH | Nymphenburger Str. 1 | 80335 Munich | Germanyinfo@xvir.com | Tel.: +49-89-99317446 | Fax: +49-89-51556413